Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer
ConclusionUsing MS-GUIDE we identified fibronectin and vitronectin as candidate biomarkers for prostate cancer risk stratification.
Source: Clinical Proteomics - Category: Biochemistry Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Learning | Prostate Cancer | Prostatectomy | Statistics | Universities & Medical Training